VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OGEN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OGENOragenics, Inc.
$0.59$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOGENQuarterly Financials

Oragenics, Inc. (OGEN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Oragenics, Inc. (OGEN) quarterly income statement — complete revenue, gross profit & net income history

OGEN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000011.04M0000000000
COGS % of Revenue--------------------
Gross Profit000000000-11.04M0000000000
Gross Margin %--------------------
Gross Profit Growth %-----100%--------------
Operating Expenses2.26M2.5M3.12M1.71M2.03M3.36M2.44M2.31M2.46M1.75M2.09M3.11M2.9M360.42K3.91M3.6M4.61M2.3M4.39M3.84M
OpEx % of Revenue--------------------
Selling, General & Admin1.61M1.83M2.19M1.26M1.68M1.69M1.56M1.4M1.8M1.75M1.33M1.12M1.25M883.57K1.22M1.04M1.33M1.08M847.13K1.37M
SG&A % of Revenue--------------------
Research & Development645.47K670.54K930.89K449.68K341.54K1.67M879.04K906.78K663.41K11.04M769.35K2.01M1.67M-523.16K2.78M2.59M3.29M1.31M3.55M2.47M
R&D % of Revenue--------------------
Other Operating Expenses000000000-1000K-7.47K-13.16K-17.02K0-86.05K-29.9K-15.08K-86.99K00
Operating Income-2.26M-2.5M-3.12M-1.71M-2.03M-3.36M-2.44M-2.31M-2.46M-12.8M-2.09M-3.11M-2.9M-360.42K-3.91M-3.6M-4.61M-2.3M-4.39M-3.84M
Operating Margin %--------------------
Operating Income Growth %-11.34%25.54%-28.17%25.66%17.64%73.78%-16.37%25.84%15.31%-3450.44%46.39%13.74%36.99%84.34%11.1%6.08%11.98%49.42%2.53%68.93%
EBITDA-2.26M-2.42M0-1.7M-2.02M-3.34M-2.45M-2.3M-2.44M-12.8M-2.09M-3.1M-2.89M-347.34K-3.89M-3.59M-4.6M-2.29M-4.38M-3.83M
EBITDA Margin %--------------------
EBITDA Growth %-11.8%27.61%100%26.2%17.43%73.91%-17.38%25.65%15.54%-3584.07%46.33%13.8%37.12%84.86%11.2%6.05%11.93%49.41%2.46%69%
D&A (Non-Cash Add-back)003.12M00000004.79K11.3K11.3K13.07K12.75K10.38K8.47K6.42K9.64K12.45K
EBIT-2.26M-2.42M-3.06M-1.7M-2.02M-3.34M-2.45M-2.3M-2.44M-12.8M-2M-3.05M-2.84M-296.85K-3.86M-3.59M-4.59M-2.29M-4.38M-3.81M
Net Interest Income37.15K79.64K61.1K-555.52K-188.92K-178-5054.6K12.15K26.39K36.44K58.11K58.85K61.18K36.41K14.55K8.66K8.7K10.71K23.22K
Interest Income40.88K87.09K68.14K16.79K10.2K10.79K9.47K6.41K19.23K38.63K50.61K58.95K62.2K66.99K41.63K15.37K11.91K13.8K17.76K24.25K
Interest Expense3.73K7.45K7.04K572.31K199.13K10.97K9.97K1.8K7.08K12.23K14.17K8433.35K5.81K5.23K8163.25K5.1K7.05K1.03K
Other Income/Expense32.06K74.52K57.18K-557.83K-190.77K6.31K-25.59K9109.27K48.9K81.56K58.73K59.98K57.76K36.41K14.92K19.13K8.54K10.71K22.62K
Pretax Income-2.22M-2.42M-3.07M-2.27M-2.22M-3.35M-2.46M-2.31M-2.45M-12.75M-2.01M-3.05M-2.84M-302.66K-3.87M-3.59M-4.59M-2.29M-4.38M-3.82M
Pretax Margin %--------------------
Income Tax-22.63K-136.91K000000000000000000
Effective Tax Rate %1.02%5.65%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-2.2M-2.29M-3.07M-2.27M-2.22M-3.35M-2.46M-2.31M-2.45M-12.75M-2.01M-3.05M-2.84M-302.66K-3.87M-3.59M-4.59M-2.29M-4.38M-3.82M
Net Margin %--------------------
Net Income Growth %0.71%31.72%-24.51%1.43%9.54%73.73%-22.36%24.44%13.85%-4111.81%47.99%15.01%38.03%86.8%11.72%5.92%12.05%48%2.51%69.07%
Net Income (Continuing)-2.2M-2.29M-3.07M-2.27M-2.22M-3.35M-2.46M-2.31M-2.45M-12.75M-2.01M-3.05M-2.84M-302.66K-3.87M-3.59M-4.59M-2.29M-4.38M-3.82M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.51-0.54-1.96-3.10-3.60-0.51-0.38-0.51-0.70-4.92-0.85-1.51-1.41-0.12-1.99-2.08-3.10-1.20-2.26-1.98
EPS Growth %85.83%-5.88%-415.79%-507.84%-414.29%89.63%55.29%66.23%50.35%-4000%57.29%27.4%54.52%90%11.95%-5.05%-1.97%63.86%50%86.03%
EPS (Basic)-0.51-0.54-1.96-3.10-3.60-0.51-0.38-0.51-0.70-4.92-0.85-1.51-1.41-0.12-1.99-2.08-3.10-1.20-2.26-1.98
Diluted Shares Outstanding4.3M4.27M15.61K7.32K607.21K6.62M6.53M4.53M3.5M2.59M2.36M2.02M2.02M2.21M1.95M1.94M1.94M1.91M1.94M1.93M
Basic Shares Outstanding4.3M4.27M15.61K7.32K607.21K6.62M6.53M4.53M3.5M2.59M2.36M2.02M2.02M2.21M1.95M1.94M1.94M1.91M1.94M1.93M
Dividend Payout Ratio--------------------